VINCITORI EXEQUO MIGLIORI COMUNICAZIONI
23 - EXPRESSION OF MATRIX ATTACHMENT REGION-BINDING PROTEINS IN HUMAN PROSTATIC CANCER: PARP-1 AND PARP-2 NEW PLAYERS IN TUMOR PROGRESSION
Paola Barboro, Nicoletta Ferrari, Sandra Salvi, Simona Boccardo, Cecilia Balbi
U.O. Traslazionale Urologica, IRCCS Azienda Ospedaliera Universitaria San Martino Istituto Nazionale per la Ricerca sul Cancro, Genova (GE), Italy
75 - CONTRAST-ENHANCED ULTRASOUND (CEUS) IN DIFFERENTIATING LOW/HIGH-GRADE BLADDER CARCINOMA THROUGH SIGNAL TIME/INTENSITALYY CURVES: PRELIMINARY DATA
Federico Lanzi1, Francesco Mazzei2, Carmen Zumpano2, Palmira Grisolia2, Federica Scipioni1, Nicola Tosi1, Filippo Gentile1, Gerardo Pizzirusso1, Aude Canale1, Filippo Cecconi1, Giovanni De Rubertis1, Gabriele Barbanti1, Maria Antonietta Centra2
1U.O.C. di Urologia, A.O.U. Senese, Siena (SI); 2U.O.C. Diagnostica per Immagini, A.O.U. Senese, Italy
POSTER VINCITORE
2 - USE OF ASPIRIN AND PROGNOSTIC RISK IN PROSTATE CANCER
Lucio Dell’Atti, Carmelo Ippolito, Gianni Ughi, Marco Sebben, Laura Fornasari, Stefano Papa, Gian Rosario Russo
Urologia, Arcispedale S. Anna, Cona (FE), Italy
POSTER SELEZIONATI
66 - ESTIMATES OF PROSTATE CANCER BURDEN IN ITALY
Roberto Foschi1, Gemma Gatta2
1Unità di Epidemiologia Valutativa, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; 2Unità di Epidemiologia Valutativa, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan
73 - DETRUSOR HYPOCONTRACTILITY AFTER OPEN RETROGRADE, ANTEGRADE AND ROBOT-ASSISTED RADICAL PROSTATECTOMY: FUNCTIONAL AND URODYNAMIC PRELIMINARY DATA
Gerardo Pizzirusso1, Federico Lanzi1, Federica Scipioni1, Nicola Tosi1, Filippo Cecconi1, Filippo Gentile1, Aude Canale1, Giovanni De Rubertis1, Gabriele Barbanti1
1U.O.C. di Urologia, A.O.U. Senese, Siena, Italy
76 - CONTRAST-ENHANCED ULTRASOUND (CEUS) IN EVALUATION OF DETRUSOR MUSCLE INVASION IN BLADDER CARCINOMAS: PRELIMINARY DATA
Federico Lanzi1, Carmen Zumpano2, Francesco Mazzei2, Nicola Tosi1, Palmira Grisolia2, Federica Scipioni1, Gerardo Pizzirusso1, Filippo Gentile1, Filippo Cecconi1, Aude Canale1, Giovanni De Rubertis1, Gabriele Barbanti1, Maria Antonietta Centra2
1U.O.C. di Urologia, A.O.U. Senese, Siena, Italy; 2U.O.C. Diagnostica per Immagini, A.O.U. Senese, Siena, Italy
86 - LIPID METHABOLISM AS THERAPEUTIC TARGET FOR PROSTATE CANCER
Claudio Festuccia1, Andrea Mancini1, Francesco Marampon1, Luca Scarsella1, Ana Jitariuc1, Alessandro Colapietro1, Ernesto Di Cesare1, Enrico Ricevuto1, Andrew Carnell2, Giovanni Luca Gravina1
1Department of Applied Clinical Sciences and Biotechnologies, Università dell’Aquila, L’Aquila, Italy; 2Department of Chemistry, Robert Robinson Laboratories, University of Liverpool
60 - IS VISCERAL ADIPOSITY INDEX (VAI) RELATED WITH PROSTATE CANCER DETECTED BY BIOPSY?
Salvatore Scurria1, Giuseppe Carità1, Salvatore Romeo1, Giovanni Caruana1, Eugenia Caltabellotta1, Ninfa Giacalone1, Roberta Modica2, Carla Giordano2, Vincenzo Serretta1
1Institute of Urology, Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Italy, Palermo (PA), Italy; 2Department of Endocrinology and Metabolic Diseases, Dibimis - University of Palermo, Palermo, Italy
6 - CARDIOVASCULAR RISK AND PROSTATE CANCER: A POSSIBLE LINK TO PROSTATE CANCER AGGRESSIVENESS
Cosimo De Nunzio1, Riccardo Lombardo1, G. Truscelli2, Hassan Fattahi1, Fabiana Cancrini1, Costantino Leonardo2, Mariangela Bellangino1, C. Gaudio2, Andrea Tubaro1, Fabrizio Presicce1
1U.O.C Urologia, Ospedale Sant’Andrea, Roma, Italy; 2U.O. Urologia, La Sapienza Policlinico Umberto I, Roma, Italy
115 - DEGARELIX INHIBITS CELL GROWTH OF THREE HUMAN PROSTATE CANCER CELL LINES
Fortunata Iacopino1, Silvia Sorrentino1, Gigliola Sica1
1Istologia ed Embriologia, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Roma, Italy
121 - SOCIO-DEMOGRAPHIC FACTORS ANDCOMORBIDITIES AS PREDICTORS OF QUALITYOF LIFE OF MEN ON ACTIVE SURVEILLANCE
Claudia Repetto1, Lara Bellardita1, Silvia Villa1,Nice Bedini2, Davide Biasoni3, Massimo Maffezzini3, Cristina Marenghi1, Sara Morlino2, Tiziana Rancati1,Tullio Torelli3, Sergio Villa2, Roberto Salvioni3,Tiziana Magnani1, Riccardo Valdagni1, 2
1Prostate Cancer Program, 2Dept. of Radiation Oncology 1,3Dept. of Urology, Fondazione IRCCS IstitutoNazionale dei Tumori, Milano, Italy
24 - TRIMODAL TREATMENT OF MUSCLE INVASIVE BLADDER CANCER IN ELDERLY PATIENTS
Rocco Luca Emanuele Liardo1, Corrado Spatola1, Emanuele Felice Rizzo1, Barbara De Pasquale1, Antonio Scuderi1, Giuseppe Privitera1
1U.O. Radiodiagnostica e Radioterapia Oncologica, Azienda Ospedaliero-Universitaria “Policlinico - Vittorio Emanuele”, Catania, Italy
79 - PROSTATE VOLUME: A TOXICITY PREDICTOR IN RADIOTHERAPY AND AN INTERESTING TARGET FOR NEOADJUVANT HORMONAL THERAPY
Girolamo Spagnoletti1, Maria Enfasi1, Giorgia Cocco1, Grazia Nardella1, Vincenzo Oriolo1, Angela Pia Solazzo1, Rita Marchese1, Ramon Gimenez De Lorenzo1, Giuseppe Bove1
1S.C. Radioterapia Oncologica, Azienda Ospedaliero-universitaria Ospedali Riuniti Foggia, Foggia, Italy
27 - AKT ACTIVATION IS INVOLVED IN OLEATE-INDUCED DOCETAXEL RESISTANCE IN ANDROGEN-INDEPENDENT PROSTATE CANCER CELLS
Matteo Ferro1, Vincenzo Cosimato2, Ada Marino2, Emilia Giorgio2, Carla Armellino2, Sara Melegari1, Antonio Brescia1, Antonio Cioffi1, Sisto Perdonà3, Vincenzo Altieri4, Daniela Terracciano2, Ottavio De Cobelli1
1Division of Urology, European Institute of Oncology, Milano, Italy; 2Division of Pathology, Dismet, University of Study of Naples-Federico II, Italy; 3Division of Urology, Istituto Nazionale Tumori - IRCCS “Fondazione G. Pascale”; 4Division of Urology, University of Salerno